Acosta-Medina AA - Search Results

1

Banks SA, Bhatti MT, Go RS, Abeykoon JP, Acosta-Medina AA, Hazim AZ, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Garrity JA, Tobin WO. Banks SA, et al. Among authors: acosta medina aa. Ophthalmology. 2023 Sep;130(9):e33-e34. doi: 10.1016/j.ophtha.2023.05.017. Epub 2023 Jun 10. Ophthalmology. 2023. PMID: 37306648 No abstract available.

2

Access to Palliative Care Services and Clinical Outcomes of Patients With Solid Malignancy-Associated Myelophthisis in a Resource-Limited Setting.

Vargas-Serafin C, Acosta-Medina AA, Teran-De-la-Sancha K, Delgado-de-la-Mora J, Bourlon MT, Bourlon C. Vargas-Serafin C, et al. Am J Hosp Palliat Care. 2021 Aug;38(8):932-937. doi: 10.1177/1049909120969963. Epub 2020 Nov 9. Am J Hosp Palliat Care. 2021. PMID: 33161730

3

Impact of Socioeconomic Characteristics and Comorbidities on Therapy Initiation and Outcomes of Newly Diagnosed Multiple Myeloma: Real-World Data From a Resource-Constrained Setting.

Vargas-Serafin C, Acosta-Medina AA, Ordonez-Gonzalez I, Martínez-Baños D, Bourlon C. Vargas-Serafin C, et al. Clin Lymphoma Myeloma Leuk. 2021 Mar;21(3):182-187. doi: 10.1016/j.clml.2020.11.020. Epub 2020 Dec 3. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33414064

4

Outcomes and Challenges of Reproductive Health in Hematopoietic Stem Cell Transplantation Survivors.

Bourlon C, Riviello-Goya S, Acosta-Medina AA, Caballero-Landinez RE, Manrique-Rubio A, Teran-De-la-Sancha K, Gulias-Herrero A, Bourlon MT. Bourlon C, et al. Biol Blood Marrow Transplant. 2020 Nov;26(11):2127-2131. doi: 10.1016/j.bbmt.2020.07.007. Epub 2020 Jul 10. Biol Blood Marrow Transplant. 2020. PMID: 32659435 Free article.

5

Isolated Extramedullary Relapse in Acute Lymphoblastic Leukemia: What Can We Do Before and After Transplant?

Riviello-Goya S, Acosta-Medina AA, Inclan-Alarcon SI, Garcia-Miranda S, Bourlon C. Riviello-Goya S, et al. Oncology (Williston Park). 2020 Feb 20;34(2):39-43. Oncology (Williston Park). 2020. PMID: 32645192

6

Latent Tuberculosis in Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Strategies to Prevent Disease Activation in an Endemic Population.

Bourlon C, Camacho-Hernández R, Fierro-Angulo OM, Acosta-Medina AA, Bourlon MT, Niembro-Ortega MD, Gonzalez-Lara MF, Sifuentes-Osornio J, Ponce-de-León A. Bourlon C, et al. Biol Blood Marrow Transplant. 2020 Jul;26(7):1350-1354. doi: 10.1016/j.bbmt.2020.03.013. Epub 2020 Mar 19. Biol Blood Marrow Transplant. 2020. PMID: 32200119 Free article.

7

HIV-positive patients presenting with peripheral blood cytopenias: is bone marrow assessment a priority?

Rajme-Lopez S, Crabtree-Ramírez B, Acosta-Medina AA, Olivas-Martínez A, Bourlon C. Rajme-Lopez S, et al. Hematol Transfus Cell Ther. 2022 Oct-Dec;44(4):542-548. doi: 10.1016/j.htct.2021.02.008. Epub 2021 May 11. Hematol Transfus Cell Ther. 2022. PMID: 34312113 Free PMC article.

8

Acute Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The Good, the Bad, and the Ugly of Isolated Extramedullary Relapse in a Latin American Population.

Arias-Espinosa L, Acosta-Medina AA, Vargas-España A, Fuentes-Martin V, Colunga-Pedraza PR, Hawing-Zarate JA, Leon AG, Soto-Mota A, Pacheco-Gutierrez G, Vargas-Serafín C, Barrera-Lumbreras G, Bourlon C. Arias-Espinosa L, et al. Among authors: acosta medina aa. Transplant Cell Ther. 2023 Aug;29(8):510.e1-510.e9. doi: 10.1016/j.jtct.2023.05.006. Epub 2023 May 10. Transplant Cell Ther. 2023. PMID: 37169289

9

Impact of Additional Cytogenetic Abnormalities on the Clinical Behavior of Patients With Chronic Myeloid Leukemia: Report on a Latin American Population.

Morales-Chacón K, Bourlon C, Acosta-Medina AA, Bourlon MT, Aguayo A, Tuna-Aguilar E. Morales-Chacón K, et al. Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):e299-e306. doi: 10.1016/j.clml.2019.02.007. Epub 2019 Feb 21. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30905538

10

Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation.

Acosta-Medina AA, Moyer AM, Go RS, Willrich MAV, Fervenza FC, Leung N, Bourlon C, Winters JL, Spears GM, Bryant SC, Sridharan M. Acosta-Medina AA, et al. Blood Adv. 2023 Feb 14;7(3):340-350. doi: 10.1182/bloodadvances.2021006416. Blood Adv. 2023. PMID: 35533258 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page